文献速递鼻科

手术患者体内氟替卡松吸收情况研究

In Vivo Fluticasone Absorption in Surgical Patients.
PubMed 文献 · Laryngoscope · 2023-09-11

本研究纳入18例术前使用氟替卡松的慢性鼻窦炎和过敏性鼻炎患者,在功能性内镜鼻窦手术和下鼻甲减容术中从鼻窦腔预定位置取组织,用质谱法定量各解剖部位的药物吸收量。结果显示下鼻甲前部吸收最高(5.7 ng/mL),其次为筛窦(4.4 ng/mL)、下鼻甲后部(3.7 ng/mL)、上颌窦(1.3 ng/mL)和蝶筛隐窝(0.72 ng/mL);修正手术患者的吸收显著高于初次手术患者。作者认为计算流体动力学模型未考虑黏液纤毛清除系统,氟替卡松在鼻窦腔内的吸收远超模型预测。

要点

  • 下鼻甲前部氟替卡松吸收最高,为5.7 ng/mL。
  • 修正手术患者吸收显著高于初次手术患者。
  • 计算流体动力学模型未考虑黏液纤毛清除,低估了药物在鼻窦腔的吸收范围。

核心结论

  • 计算流体动力学模型有助于预测鼻腔颗粒流,但未纳入黏液纤毛清除系统,氟替卡松在鼻窦腔内的吸收远超这些模型的预测。

研究设计与样本

  • 招募术前使用氟替卡松的慢性鼻窦炎和过敏性鼻炎患者,分别拟行功能性内镜鼻窦手术和下鼻甲减容术。
  • 术中从鼻窦腔预定位置获取组织样本,用质谱法定量各解剖部位的吸收量。
  • 共纳入18例患者。

主要发现

  • 氟替卡松吸收量从高到低依次为下鼻甲前部5.7 ng/mL、筛窦4.4 ng/mL、下鼻甲后部3.7 ng/mL、上颌窦1.3 ng/mL、蝶筛隐窝0.72 ng/mL。
  • 修正手术患者的吸收显著高于初次手术患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intranasal corticosteroids (INCS) are a treatment mainstay of chronic rhinosinusitis and allergic rhinitis. Current computational models demonstrate that >90% of INCS drug deposition occurs on the head of the inferior turbinate and nasal valve, rather than the actual sinuses. These models do not consider mucociliary clearance which propels mucus posteriorly, nor do they consider the absorption of the drug. The purpose of this study is to better understand the exact anatomical location where INCS are absorbed. METHODS: Patients with chronic rhinosinusitis and allergic rhinitis taking fluticasone pre-operatively who were scheduled for functional endoscopic sinus surgery and inferior turbinate reduction, respectively, were recruited. Intra-operative tissue samples were obtained from predetermined locations within the sinonasal cavity. Mass spectrometry was then used to quantify the amount of absorption in each specific anatomic location to determine the largest amount of absorption. RESULTS: Eighteen patients were included in our study. The greatest fluticasone absorption levels across the sinonasal anatomy were at the anterior inferior turbinate (5.7 ngl/mL), ethmoid sinus, (4.4 ng/mL), posterior inferior turbinate (3.7 ng/mL), maxillary sinus (1.3 ng/mL), and the sphenoethmoidal recess (0.72 ng/mL) respectively. Absorption was significantly higher in revision surgery compared to surgically naïve patients. CONCLUSIONS: Computation fluid dynamic models of the nasal passage are useful models to help predict intranasal particle flow. However, these models do not incorporate or consider the important mucociliary clearance system, leading to absorption of fluticasone throughout the sinonasal cavity far beyond that predicted by these models. LEVEL OF EVIDENCE: 2 Laryngoscope, 134:1551-1555, 2024.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Lee SE, Ritter E, Nguyen TT, et al. In Vivo Fluticasone Absorption in Surgical Patients. Laryngoscope. 2023. PMID: 37694807. doi:10.1002/lary.31050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。